These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 24806271)

  • 1. [Medical treatment of Parkinson's disease in elderly and multimorbid patients].
    Lettow I; Röther J
    Internist (Berl); 2014 Jun; 55(6):728-34. PubMed ID: 24806271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term Effectiveness of Adjuvant Treatment With Catechol-O-Methyltransferase or Monoamine Oxidase B Inhibitors Compared With Dopamine Agonists Among Patients With Parkinson Disease Uncontrolled by Levodopa Therapy: The PD MED Randomized Clinical Trial.
    Gray R; Patel S; Ives N; Rick C; Woolley R; Muzerengi S; Gray A; Jenkinson C; McIntosh E; Wheatley K; Williams A; Clarke CE;
    JAMA Neurol; 2022 Feb; 79(2):131-140. PubMed ID: 34962574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current pharmacotherapeutic treatment options in Parkinson's disease.
    Rezak M
    Dis Mon; 2007 Apr; 53(4):214-22. PubMed ID: 17586328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guideline for the treatment of Parkinson's disease.
    Carr J; Kies B; Fine J;
    S Afr Med J; 2009 Oct; 99(10):755-6, 758. PubMed ID: 20128276
    [No Abstract]   [Full Text] [Related]  

  • 5. The comparative effects of medical therapies for Parkinson's disease.
    Horn S; Stern MB
    Neurology; 2004 Oct; 63(7 Suppl 2):S7-12. PubMed ID: 15477585
    [No Abstract]   [Full Text] [Related]  

  • 6. Drugs for Parkinson's disease.
    Treat Guidel Med Lett; 2011 Jan; 9(101):1-6; quiz 2 p following 6. PubMed ID: 21304446
    [No Abstract]   [Full Text] [Related]  

  • 7. Modes of drug delivery used to manage Parkinson's disease.
    Noble C
    Nurs Times; 2006 Aug 8-14; 102(32):30-2. PubMed ID: 16922099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parkinson's disease: medical treatment of moderate to advanced disease.
    Suchowersky O
    Curr Neurol Neurosci Rep; 2002 Jul; 2(4):310-6. PubMed ID: 12044250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in inpatient antiparkinson drug use in the USA, 2001-2012.
    Crispo JA; Fortin Y; Thibault DP; Emons M; Bjerre LM; Kohen DE; Perez-Lloret S; Mattison D; Willis AW; Krewski D
    Eur J Clin Pharmacol; 2015 Aug; 71(8):1011-9. PubMed ID: 26081062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drugs for Parkinson's disease.
    Cranwell-Bruce LA
    Medsurg Nurs; 2010; 19(6):347-9, 355; quiz 350. PubMed ID: 21337993
    [No Abstract]   [Full Text] [Related]  

  • 11. Medical and surgical care for patients with Parkinson's disease.
    Daud DB; McDonald C
    Br J Hosp Med (Lond); 2018 Nov; 79(11):C162-C166. PubMed ID: 30418822
    [No Abstract]   [Full Text] [Related]  

  • 12. Community and long-term care management of Parkinson's disease in the elderly: focus on monoamine oxidase type B inhibitors.
    Chen JJ; Fernandez HH
    Drugs Aging; 2007; 24(8):663-80. PubMed ID: 17702535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guidelines for the management of Parkinson's disease. The Parkinson's Disease Consensus Working Group.
    Bhatia K; Brooks DJ; Burn DJ; Clarke CE; Playfer J; Sawle GV; Schapira AH; Stewart D; Williams AC
    Hosp Med; 1998 Jun; 59(6):469-80. PubMed ID: 9775275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment Strategies in Early Parkinson's Disease.
    Marsili L; Marconi R; Colosimo C
    Int Rev Neurobiol; 2017; 132():345-360. PubMed ID: 28554414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacotherapy for Parkinson's disease.
    Chen JJ; Swope DM
    Pharmacotherapy; 2007 Dec; 27(12 Pt 2):161S-173S. PubMed ID: 18041936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Initial treatment of Parkinson's disease in 2016: The 2000 consensus conference revisited.
    Laurencin C; Danaila T; Broussolle E; Thobois S
    Rev Neurol (Paris); 2016; 172(8-9):512-523. PubMed ID: 27476416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The treatment of Parkinson's disease].
    Baumann CR; Waldvogel D
    Praxis (Bern 1994); 2013 Dec; 102(25):1529-35. PubMed ID: 24326048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The role of inhibitors of COMT and MAO-B in the therapy of Parkinson's disease].
    Woitalla D; Krüger R; Lorenzl S; Müller T; Oelwein G; Storch A; Wolz M; Wüllner U
    Fortschr Neurol Psychiatr; 2020 Sep; 88(9):620-633. PubMed ID: 32588409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current strategies in the treatment of Parkinson's disease and a personalized approach to management.
    Diaz NL; Waters CH
    Expert Rev Neurother; 2009 Dec; 9(12):1781-9. PubMed ID: 19951137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternatives to levodopa in the initial treatment of early Parkinson's disease.
    Lees A
    Drugs Aging; 2005; 22(9):731-40. PubMed ID: 16156677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.